Back to Results
First PageMeta Content
Lactams / Biology / PDE5 inhibitors / Pyridines / Pfizer / CGMP-specific phosphodiesterase type 5 / Phosphodiesterase / Tadalafil / PDE3 / Chemistry / Organic chemistry / Molecular biology


Document Date: 2014-03-03 21:03:11

Open Document

File Size: 402,58 KB

Share Result on Facebook

Company

Wiley-VCH Verlag GmbH & Co. KGaA / Ó 2014 Wiley-VCH Verlag GmbH & Co. KGaA / Reuters / /

Event

Patent Issuance / /

IndustryTerm

treatment of male erectile dysfunction / treatment of depression / biotechnology / treatment of schizophrenia and Huntington’s disease / treatment of cognitive disorders / pharmaceutical / /

MedicalCondition

intermittent claudication / vascular disease / benign prostatic hypertrophy / atopic dermatitis / BPH / COPD / schizophrenia / disease / atherosclerosis / male erectile dysfunction / malaria / chronic obstructive pulmonary disease / stroke / Huntington’s disease / severe nausea / pulmonary hypertension / cognitive disorders / Chagas disease / sudden cardiac arrest / muscle contraction / diseases / renal disease / angina / depression / respiratory diseases / disorders / severe chronic obstructive pulmonary disease / asthma / /

Organization

World Health Organization / /

Person

Spiros Liras / Andrew S. Bell / /

Product

amrinone / adenosine / /

Technology

molecular modeling / biotechnology / drug design / /

SocialTag